Expanded Access Policy

Policy on Expanded Access to Investigational Therapies

Oftentimes, patients who are suffering from severe or life-threatening conditions may seek access to an investigational therapy prior to those therapies being approved by a regulatory body. In these cases, patients may make a request directly to a company to obtain access to a therapy through a program called expanded access, which is sometimes also referred to as compassionate use. Expanded access is defined as use of an experimental drug outside of a clinical trial and requires the approval of a regulatory body like the Food and Drug Administration in the United States, or the European Medicines Agency in the European Union.

uniQure Logo Twitter Icon LinkedIn Icon YouTube Icon Twitter Icon Arrow Slideshow Next Button